AARVIK THERAPEUTICS

Welcome to the Brand page for “AARVIK THERAPEUTICS”, which is offered here for Pharmaceutical products for the prevention and treatment cancer, infectious and neurologic diseases and disorders; pharmaceutical preparations for the diagnosis and treatment of cancer, infectious and neurologic diseases and disorders; pharmaceutical preparations, substances and compositions, medical diagnostic reagents in the nature of mono-specific antibodies, bi-specific, and multi-specific antibodies, antibody-drug conjugates, t cell, nk cell, and macrophage engaging antibodies, all for use in oncology, neurology and infectious disease diagnostics and treatment;therapeutics;scientific research for medical purposes in the field of cancer, infectious and neurologic diseases and disorders; research and development services in the field of antibodies; scientific and technological services and research relating thereto, scientific research, analysis and testing in the fields of mono-specific antibodies, bi-specific, multi-specific antibodies; antibody-drug conjugates, t cell, nk cell, and macrophage engaging antibodies; antibody engineering; custom design and engineering of antibodies; research and development of pharmaceuticals for the treatment of cancer, infectious and neurologic diseases and disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; research development and establishment of testing specifications and procedures in the field of cancer research, and scientific research in the field of cancer diagnosis and treatment; providing scientific research information in the field of cancer research, and providing scientific research information in the field of cancer diagnosis and treatment;.

Its status is currently believed to be active. Its class is unavailable. “AARVIK THERAPEUTICS” is believed to be currently owned by “AARVIK THERAPEUTICS, INC.”